Aroa Biosurgery’s Myriad product family was a star performer of the company’s first profit since listing in 2020 and is ...

Aroa Biosurgery Ltd (AU:ARX) has released an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top StocksMake ...

Myriad products are a strong performer for Aroa, accounting for 38% of total sales and 72% of its direct sales mix in H1 FY25. Sales of the product range surged to NZ$14.8m during the half year, ...